Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine G Kohn

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
BMJ Open|November 8, 2015
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspectiveCraig I Coleman, Nick Freemantle, Christine G Kohn
Current Medical Research and Opinion|June 16, 2015
Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction ruleCraig I Coleman, Christine G Kohn, Thomas J Bunz
Expert Review of Pharmacoeconomics & Outcomes Research|November 10, 2016
Economics of ramucirumab for metastatic colorectal cancerSimon B Zeichner, Christine G Kohn, Daniel A Goldstein
Postgraduate Medicine|May 14, 2019
The non-medical switching of prescription medicationsRichard Dolinar, Christine G Kohn, Frank Lavernia, et al.
Plos One|October 22, 2013
Short-term consequences of angiographically-confirmed coronary stent thrombosisChristine G Kohn, Jeffrey Kluger, Meena Azeem, et al.
International Journal of Cardiology|September 30, 2018
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-lifeElaine Nguyen, Craig I Coleman, Christine G Kohn, et al.
European Journal of Haematology|October 18, 2018
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolismChristine G Kohn, Thomas J Bunz, Jan Beyer-Westendorf, et al.
The Patient|October 1, 2013
Walking speed and health-related quality of life in multiple sclerosisChristine G Kohn, William L Baker, Matthew F Sidovar, et al.
The American Journal of Cardiology|February 25, 2014
Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectorisChristine G Kohn, Matthew W Parker, Brendan L Limone, et al.
Health and Quality of Life Outcomes|March 18, 2014
Impact of angina frequency on health utility values of patients with chronic stable anginaChristine G Kohn, Matthew W Parker, Brendan L Limone, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
BMJ Open|November 8, 2015
Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspectiveCraig I Coleman, Nick Freemantle, Christine G Kohn
Current Medical Research and Opinion|June 16, 2015
Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction ruleCraig I Coleman, Christine G Kohn, Thomas J Bunz
Expert Review of Pharmacoeconomics & Outcomes Research|November 10, 2016
Economics of ramucirumab for metastatic colorectal cancerSimon B Zeichner, Christine G Kohn, Daniel A Goldstein
Postgraduate Medicine|May 14, 2019
The non-medical switching of prescription medicationsRichard Dolinar, Christine G Kohn, Frank Lavernia, et al.
Plos One|October 22, 2013
Short-term consequences of angiographically-confirmed coronary stent thrombosisChristine G Kohn, Jeffrey Kluger, Meena Azeem, et al.
International Journal of Cardiology|September 30, 2018
Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-lifeElaine Nguyen, Craig I Coleman, Christine G Kohn, et al.
European Journal of Haematology|October 18, 2018
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolismChristine G Kohn, Thomas J Bunz, Jan Beyer-Westendorf, et al.
The Patient|October 1, 2013
Walking speed and health-related quality of life in multiple sclerosisChristine G Kohn, William L Baker, Matthew F Sidovar, et al.
The American Journal of Cardiology|February 25, 2014
Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectorisChristine G Kohn, Matthew W Parker, Brendan L Limone, et al.
Health and Quality of Life Outcomes|March 18, 2014
Impact of angina frequency on health utility values of patients with chronic stable anginaChristine G Kohn, Matthew W Parker, Brendan L Limone, et al.
Pageof 4